Gamma Investing LLC Day One Biopharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.01 Trillion
- Q3 2024
A detailed history of Gamma Investing LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 68 shares of DAWN stock, worth $905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68
Previous 42
61.9%
Holding current value
$905
Previous $579,000
63.56%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$105 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$85.6 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$78.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$64.9 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$60.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $978M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...